SHL Medical

SHL Medical SHL Medical is a pioneering leader in advanced self-injection solutions such as autoinjectors and pen injectors.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients’ independence. View SHL Medical trademarks: https://www.shl-medical.com/trademarks

South Carolina’s life sciences industry continues to gain momentum, and we recently had the opportunity to highlight tha...
02/06/2026

South Carolina’s life sciences industry continues to gain momentum, and we recently had the opportunity to highlight that progress during Mayor Reginald Burgess’ visit to SHL Medical’s North Charleston site.

From discussions on manufacturing and workforce development to a tour of our autoinjector production facility, the visit offered a closer look at the technologies and operations supporting SHL Medical’s expanding manufacturing presence in the US.

During the visit, Mayor Burgess joined our North Charleston team in recognizing the 100th shipment delivered to one of our pharma partners, marking an important milestone in the site’s continued growth.

Conversations with our team members also highlighted how advanced manufacturing supports the Lowcountry’s evolving life sciences sector while reflecting SHL Medical’s focus on manufacturing, innovation, and workforce growth. Since establishing operations in the state, SHL Medical has created hundreds of jobs and continues to expand our footprint in the region.

We thank Mayor Burgess for taking the time to visit our site and engage in discussions on the continued growth of manufacturing and life sciences in South Carolina.

Subcutaneous delivery is pushing past the conventional 1.0–2.0 mL range, and the discussion is shifting from how can we ...
01/06/2026

Subcutaneous delivery is pushing past the conventional 1.0–2.0 mL range, and the discussion is shifting from how can we deliver larger volumes to how do we make it work in practice.
​
At the Drug-Device Combination Products for Parenteral Use 2026 workshop in Basel, SHL Medical’s Alex Lyness, PhD, will present at the podium and join a panel discussion on what it takes to enable large-volume subcutaneous injection. These sessions will explore how increasing injection volumes and formulation complexity are reshaping device design, particularly in the 2.0–5.0 mL space, where delivery approaches are still evolving.
​
If you’re interested in how large-volume subcutaneous delivery is evolving, we welcome you to join the sessions at Novotel Basel City on June 10.

Multiple sclerosis is often diagnosed when life is still taking shape: careers beginning, families growing, independence...
30/05/2026

Multiple sclerosis is often diagnosed when life is still taking shape: careers beginning, families growing, independence expanding, and plans changing. For many people, diagnosis and long-term treatment become part of that same life stage.

This , we join the campaign in calling for earlier and accurate diagnosis, as well as stronger support for the MS community.

At SHL Medical, our role begins in what comes next. Since 2012, we have worked with pharma partners to develop self-injection systems for biologics, complex polypeptides, and generics used in MS treatment, contributing to a broader track record across more than 60 combination product launches worldwide.

As MS care continues to evolve, we are proud to support solutions that help long-term care fit more naturally into the lives people are building. 🧡

Learn more about our track record: https://bit.ly/3P6c5qc

Seeing a real automated production line up close can make an industry feel very different from what people imagine.​At S...
29/05/2026

Seeing a real automated production line up close can make an industry feel very different from what people imagine.
​
At SHL Medical’s Taiwan site, students from electronics and information technology classes at Wu-Ling Senior High School stepped beyond the classroom to get a closer look at the technologies, engineering, and production environments behind medical device manufacturing.
​
Our colleagues Nathan Chiu from the Quality Engineering team and Christoph Schindler from SHL Advantec shared insights into medical device manufacturing and how automated production lines are planned and built, including how software and hardware are brought together in real production environments.
​
Many students were especially curious about the automation technologies used in large-scale production. Touring our production lines also helped bring those conversations to life by giving students the chance to see these technologies operating firsthand.
​
For SHL Medical, experiences like these are an opportunity to help future talent better understand the industry and discover new possibilities for where engineering can be applied in healthcare.

In lyophilized drug delivery, it is not enough for the system to work. The device, reconstitution approach, and assembly...
28/05/2026

In lyophilized drug delivery, it is not enough for the system to work. The device, reconstitution approach, and assembly strategy must also be seamlessly aligned to support a realistic path to commercialization.

At PFS and IDD West Coast, SHL Medical's Dr. Nina Fetz will be speaking about these early development considerations in lyophilized drug delivery, and what they can mean for pharma teams as they move beyond technical feasibility through a real-world case study.

The session will also feature Reunite, our dual-chamber cartridge autoinjector for lyophilized drug delivery. Built with our proprietary Needle Isolation Technology (NIT), it simplifies a complex vial-based injection process into just three steps.

Join us in San Diego to continue the conversation.

10 years. 20+ approved combination products. Nearly 30 therapeutic indications. More than 210 million devices reaching p...
27/05/2026

10 years. 20+ approved combination products. Nearly 30 therapeutic indications. More than 210 million devices reaching patients globally.

This is what a decade of Molly looks like.

Featured in the latest issue of ONdrugDelivery magazine, Nicholas Heaton, SHL Medical's Global Head of Sales, looks back on the evolution of the Molly autoinjector platform over the past decade and its role in supporting reliable, scalable drug delivery solutions for pharma customers bringing self-injection therapies to patients worldwide.

Read the full interview 👉 https://bit.ly/4fNF9xg

26/05/2026

Building for volume means holding two things at once: the precision your customer expects, and the economics that make it viable.

During Quanta’s development, close collaboration with molding and assembly experts helped guide key choices, from accelerating learning through higher-fidelity prototypes to defining targets for tolerances and component complexity.

Device platforms are often chosen for efficiency, consistency, and scale across multiple products and biosimilars.The ha...
25/05/2026

Device platforms are often chosen for efficiency, consistency, and scale across multiple products and biosimilars.

The harder question comes later: how do you manage change when the platform needs to evolve?

Join Dr. Nina Fetz of SHL Medical and Katy Rommel, PhD, of Kymanox for a webinar on the practical and regulatory realities of device platform evolution in drug-device combination products.

The discussion will cover regulatory and user impact, EDDOs, user interfaces, bridging studies, and governance controls.

📌 June 22, 2026 | 3 PM CEST / 9 AM ET

Register for the webinar: https://bit.ly/4dZVjCw

Manufacturing growth is about more than just building a factory. Long-term success also depends on the infrastructure, p...
22/05/2026

Manufacturing growth is about more than just building a factory. Long-term success also depends on the infrastructure, planning, and partnerships that support the region around it.
​
As part of Economic Development Week, SHL Medical hosted the Palmetto Commerce Park Roundtable at our North Charleston manufacturing facility. The event brought together regional leaders and local businesses for discussions on infrastructure, emergency preparedness, and the continued development of the Palmetto Commerce Park area.
​
Attendees also toured our site and experienced firsthand how SHL Medical continues to expand manufacturing capabilities while supporting South Carolina’s growing life sciences ecosystem.
​
Thank you to Charleston County Economic Development, the City of North Charleston, and Charleston County Government Emergency Management for the valuable conversations and collaboration. Close partnerships across industry and community continue to play an important role in supporting long-term growth and innovation in the region.

21/05/2026

Addressing sustainability late in development means working around constraints you built yourself.

For Quanta, sustainability was considered from the start. From the outset, targets were defined around reducing device carbon footprint and minimizing plastic use while maintaining device performance. Eco-design principles guided the entire development process, from material selection to the use of certified bio-circular materials and recyclable packaging.

Adresse

Gubelstrasse 22
Zug
6300

Webseite

https://www.shl-medical.com/trademarks

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von SHL Medical erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an SHL Medical senden:

Verknüpfungen

Teilen